Welcome to our dedicated page for CAMTEK SEC filings (Ticker: CAMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Camtek Ltd. filings document foreign-issuer current reports on operating results, customer orders, investor presentations, material agreements, capital structure and governance. The company’s Form 6-K disclosures include financial-result releases, order announcements for semiconductor inspection and metrology systems, and operating and financial review materials.
Camtek’s regulatory record also covers capital-structure activity, including convertible senior notes due 2030, and risk disclosures tied to semiconductor capital spending, demand for HPC, HBM and chiplet devices, global trade and export restrictions, and geographic concentration in Asia Pacific markets. These filings describe the company as a Nasdaq- and TASE-listed supplier serving IDMs, OSATs and foundries.
CAMTEK LTD officer Orit Geva-Dvash, Vice President of HR, reported selling 508 Ordinary Shares of CAMT on 2026-08-17 in an open market or private transaction at $175.00 per share. Following this sale, she directly holds 5,205 Ordinary Shares. The Rule 10b5-1 trading-plan checkbox was not marked as used.
Camtek Ltd. shareholder Orit Geva Dvash has notified an intention to sell 508 Ordinary Shares of Camtek through Oppenheimer & Co. Inc., with an indicated value of $87,787.48, on 08/17/2026 on Nasdaq.
The holder previously received 3,557 Ordinary Shares on 01/16/2024 upon vesting of RSUs for no cash consideration, and has sold 415 Ordinary Shares in the last three months on 08/12/2026 for $72,235.85.
CAMTEK LTD director Andorn Karni Yarl reported option exercises and share sales in August 2026. On August 14, stock options for 3,176 Ordinary Shares at an exercise price of $22.63 per share were exercised and the resulting shares were sold at $164.40 per share. On August 13, options for 880 shares at $63.51 were exercised and the resulting shares were sold in multiple transactions, including 880 shares at $172.7428 and 1,476 shares at a weighted average price of $172.1221 per share, with detailed price ranges disclosed in a footnote. The options and underlying shares referenced in certain transactions were exercised and sold on the same dates.
Camtek Ltd (CAMT) Chief Operating Officer Ram Langer reported a sale of 6,387 Ordinary Shares on 2026-08-13 in an open-market or private transaction. The shares were sold at a weighted average price of $172.3222 per share, with individual trade prices ranging from $172.13 to $172.72. Following this transaction, Langer directly holds 17,532 Ordinary Shares. The transaction was not reported as made under a Rule 10b5-1 trading plan.
CAMTEK LTD Chief Executive Officer Rafi Amit reported selling 6,250 Ordinary Shares of CAMT on 2026-08-13 in a sale classified as an open market or private transaction at a price of $170.52 per share. Following this transaction, he directly holds 55,350 Ordinary Shares. The sale was not marked as being made under a Rule 10b5-1 trading plan.
Camtek Ltd. investor Yael Andorn filed a Form 144 notice for a proposed sale of 3,176 ordinary shares of Camtek Ltd., to be handled through Oppenheimer & Co. Inc. on or after 08/14/2026 on Nasdaq. The shares are described as having been acquired upon the exercise of employee stock options, with a cash payment made upon exercise of those options.
The filing also lists securities sold during the past three months, showing that on 08/13/2026 Andorn sold 2,356 ordinary shares for an aggregate amount of 406,065.92. The Form 144 serves as an advance notice of the potential future sale of restricted or control shares.
Camtek Ltd. filed a notice of proposed sale of 6,250 Ordinary Shares through Oppenheimer & Co. Inc. on Nasdaq, with an aggregate market value of $1,088,750.00, based on 45,828,133 Ordinary Shares outstanding as of the notice. The filing also lists prior issuances of Ordinary Shares upon vesting of RSUs on 01/24/2023 (15,145 shares), 02/16/2023 (10,097 shares), and 01/16/2024 (19,878 shares), all issued for no cash consideration.
Camtek Ltd has a notice to sell 2,356 Ordinary Shares on Nasdaq through Oppenheimer & Co. Inc., with the entry dated 08/13/2026. The shares to be sold were acquired from equity compensation: 1,082 shares issued upon vesting of RSUs on 12/21/2023, 394 shares issued upon vesting of RSUs on 09/25/2024, and 880 shares acquired upon exercise of employee stock options on 08/13/2026. The RSU shares were received for no cash consideration, while the option shares required a cash payment upon exercise.
A shareholder of Camtek Ltd. filed to potentially sell 6,387 Ordinary Shares, with an aggregate market value of $1,112,615.40, on or after August 13, 2026 through Oppenheimer & Co. Inc. on Nasdaq. The filing also lists prior Ordinary Shares issued upon vesting of RSUs on January 16, 2024 (12,701 shares) and April 1, 2025 (2,872 and 1,701 shares) for no cash consideration.
CAMTEK LTD vice president of HR, Orit Geva-Dvash, reported a sale of 415 Ordinary Shares of CAMT on 2026-08-12 at $174.0623 per share in an open-market or private transaction. Following this sale, she directly holds 5,713 Ordinary Shares, a balance that includes one additional share previously omitted from her Form 3 due to a rounding error. The filing does not indicate that this trade was made under a Rule 10b5-1 trading plan.